Jochen Probst
36Patents
22h-index
20Co-inventors
81Inventor score
Filing activity: Jan 8, 2008 → Jul 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9669089B2 | Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen | Emerging Cross-Sectional Technologies | 92 | Active |
| US9447431B2 | Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein | Chemistry; Metallurgy | 57 | Active |
| US9226959B2 | Nucleic acids comprising formula (NuGlXmGnNv)a and derivatives thereof as immunostimulating agent/adjuvant | Emerging Cross-Sectional Technologies | 45 | Active |
| US10293058B2 | RNA containing composition for treatment of tumor diseases | Emerging Cross-Sectional Technologies | 41 | Active |
| US9234013B2 | Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein | Emerging Cross-Sectional Technologies | 37 | Active |
| US10912826B2 | Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen | Emerging Cross-Sectional Technologies | 34 | Active |
| US9839697B2 | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein | Emerging Cross-Sectional Technologies | 32 | Active |
| US10111968B2 | Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein | Chemistry; Metallurgy | 30 | Active |
| US10918740B2 | RNA containing composition for treatment of tumor diseases | Emerging Cross-Sectional Technologies | 29 | Active |
| US10166283B2 | Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen | Emerging Cross-Sectional Technologies | 27 | Active |
| US10010592B2 | Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen | Chemistry; Metallurgy | 26 | Active |
| US9974845B2 | Combination of vaccination and inhibition of the PD-1 pathway | Emerging Cross-Sectional Technologies | 25 | Active |
| US10117920B2 | Combination of vaccination and inhibition of the PD-1 pathway | Emerging Cross-Sectional Technologies | 25 | Active |
| US9352028B2 | Composition for treating lung cancer, particularly of non-small lung cancers (NSCLC) | Human Necessities | 24 | Active |
| US10434158B2 | Combination of vaccination and inhibition of the PD-1 pathway | Emerging Cross-Sectional Technologies | 24 | Active |
| US10232024B2 | Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigen | Emerging Cross-Sectional Technologies | 24 | Active |
| US10682406B2 | Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen | Emerging Cross-Sectional Technologies | 23 | Active |
| US10869935B2 | RNA containing composition for treatment of tumor diseases | Emerging Cross-Sectional Technologies | 23 | Active |
| US9402887B2 | Composition for treating prostate cancer (PCa) | Human Necessities | 23 | Active |
| US10017826B2 | Method for producing RNA | Chemistry; Metallurgy | 23 | Active |
| US10434154B2 | Composition for treating prostate cancer (PCa) | Human Necessities | 23 | Active |
| US11110156B2 | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen | Chemistry; Metallurgy | 22 | Active |
| US10898589B2 | Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein | Chemistry; Metallurgy | 22 | Active |
| US11268157B2 | Method for producing RNA | Chemistry; Metallurgy | 22 | Active |
| US10441653B2 | Nucleic acid comprising GlXmGn as an immune-stimulating agent/adjuvant | Chemistry; Metallurgy | 22 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.